PUBLIC COMPANY
saveRising Pharma Holdings Inc
updated 4mo ago
community read0 votes
🐶 often sniffed alongside
top 8- tagRecall5 co-mentions · 5 sources
- drugSINEMET CR3 co-mentions · 1 sources
- druglevodopa3 co-mentions · 1 sources
- druglevodopa CR3 co-mentions · 1 sources
- drugentacapone3 co-mentions · 1 sources
- drugINBRIJA3 co-mentions · 1 sources
- drugCETIRIZINE HYDROCHLORIDE2 co-mentions · 2 sources
- drugcetirizine hydrochloride ODT2 co-mentions · 2 sources
pipeline
14
marketed
11
phase 3
0
catalysts ytd
19
approvals ytd
18
recalls ytd
0
Pipeline(14)
view full pipeline →pipeline depth14 products
11Marketed3Unknown
Marketed
(captopril + hydrochlorothiazide)
Hypertension
Marketed(carbidopa + levodopa) ODT
Parkinson's Disease
MarketedFENTANYL CITRATE
General Anesthetic Effect
MarketedLotensin HCT
Hypertension
MarketedTOREMIFENE CITRATE
Metastatic Breast Cancer
Marketedalfentanil hydrochloride
General Anesthetic Effect
Marketedindapamide
Edema
Marketedpentoxifylline ER
Intermittent Claudication
Marketedriluzole
Amyotrophic Lateral Sclerosis
Marketedtolmetin sodium
Juvenile Rheumatoid Arthritis
Marketedtriamcinolone acetonide Rising
Atopic Dermatitis (Atopic Eczema)
drugALFENTA
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →🐶 Hiring Signal
News
- Unique Pharmaceutical Laboratories (A Div. of J. B. Chemicals & Pharmaceuticals Ltd.) Issues Voluntary Nationwide Recall of Cetirizine Hydrochloride Tablets USP 5 mg Due to Potential Cross Contamination with RanitidineFOR IMMEDIATE RELEASE – July 18th, 2026 – Panoli, Gujarat, Unique Pharmaceutical Laboratories (A Div. of J. B. Chemicals & Pharmaceuticals Ltd.) is voluntarily recalling four lots of Cetirizine Hyd…fda_medwatch · 2mo ago
Data sources
Found something off?
comments(0)
5-min edit window · permanent after that